SHC — Sotera Health Co Cashflow Statement
0.000.00%
- $3.17bn
- $5.21bn
- $1.10bn
- 77
- 26
- 63
- 55
Annual cashflow statement for Sotera Health Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -37.5 | 117 | -234 | 51.4 | 44.4 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 49.7 | 29.8 | 30.7 | 77.8 | 14.3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -11.8 | -12.6 | 409 | -438 | -7.63 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 121 | 282 | 278 | -148 | 224 |
Capital Expenditures | -53.5 | -102 | -182 | -215 | -179 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -105 | -57.7 | 0.482 | 0.069 | 0.074 |
Acquisition of Business | |||||
Sale of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -159 | -160 | -182 | -215 | -179 |
Financing Cash Flow Items | -21.2 | -17.3 | -2.24 | -31.5 | -38.8 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 73.4 | -117 | 198 | 266 | -50.6 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 39.4 | 4.47 | 289 | -94.6 | -22.8 |